Literature DB >> 31855530

Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia.

Khalid H Alanazi, Glen R Abedi, Claire M Midgley, Abdulrahim Alkhamis, Taghreed Alsaqer, Abdullah Almoaddi, Abdullah Algwizani, Sameeh S Ghazal, Abdullah M Assiri, Hani Jokhdar, Susan I Gerber, Hail Alabdely, John T Watson.   

Abstract

Diabetes mellitus and hypertension are recognized risk factors for severe clinical outcomes, including death, associated with Middle East respiratory syndrome coronavirus infection. Among 32 virus-infected patients in Saudi Arabia, severity of illness and frequency of death corresponded closely with presence of multiple and more severe underlying conditions.

Entities:  

Keywords:  MERS-CoV; Middle East respiratory syndrome coronavirus; Saudi Arabia; death; diabetes mellitus; hypertension; infection; underlying conditions; vector-borne infections; viruses; zoonoses

Mesh:

Year:  2020        PMID: 31855530      PMCID: PMC6924889          DOI: 10.3201/eid2601.190952

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


First described in 2012, infection with Middle East respiratory syndrome coronavirus (MERS-CoV) has been reported worldwide. More than 2,200 cases have been reported to the World Health Organization, and more than one third have resulted in death (). Certain underlying conditions, including diabetes mellitus (DM), hypertension, chronic cardiac disease, and chronic renal disease, are recognized risk factors for illness and death caused by infection with MERS-CoV (,). We further explored this relationship among MERS patients admitted to a referral hospital in Riyadh, Saudi Arabia, during August 1, 2015–August 31, 2016. Enrollment criteria and data collection methods have been described (). We considered persons with a medical history of DM as having documented DM and persons with multiple recorded periods of hyperglycemia during hospitalization as having possible DM (). We similarly identified patients with hypertension or chronic kidney disease (CKD) by using documentation in the medical chart. We defined cardiovascular disease as having documentation of coronary artery disease or a history of heart failure or stroke. We considered patients with cardiovascular disease or CKD to have chronic organ damage (COD). We performed statistical analysis by using SAS version 9.4 (https://www.sas.com) and Microsoft Excel (https://www.microsoft.com). Of 33 enrolled patients, medical history was available for 32 through medical charts. Underlying disease status among the 32 patients were no DM, hypertension, or COD (n = 11); DM without hypertension or COD (n = 5); DM and hypertension without COD (n = 5); and DM or hypertension with COD (n = 11). Of the 21 patients who had DM, 19 had DM documented in the medical chart, and 2 had possible DM, with random glucose readings >350 mg/dL during hospitalization. All 15 patients with hypertension had concomitant DM (Figure; Appendix Table). Of the 11 patients who had COD, 8 had cardiovascular disease, 1 had CKD, and 2 had cardiovascular disease and CKD. Of the 10 patients who had cardiovascular disease, 5 had a history of coronary disease, 3 had a history of heart failure, and 4 had a history of stroke; of the 3 patients with a history of heart failure, 1 also had coronary disease and 1 had a history of stroke.
Figure

Characteristics of 32 case-patients infected with Middle East respiratory syndrome coronavirus, by underlying condition and survival status, Saudi Arabia. 1, DM defined as hyperglycemia recorded during hospitalization (n = 2). 2a, chronic lung disease in 1 patient with no DM or HTN who survived, 1 patient with DM and HTN but no COD who died, and 1 patient with CVD and not CKD who died. 2b, epilepsy in 1 patient with CVD and CKD who died. 2c, uterine cancer in 1 patient with CVD and not CKD who died. COD, chronic organ damage; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; HTN, hypertension.

Characteristics of 32 case-patients infected with Middle East respiratory syndrome coronavirus, by underlying condition and survival status, Saudi Arabia. 1, DM defined as hyperglycemia recorded during hospitalization (n = 2). 2a, chronic lung disease in 1 patient with no DM or HTN who survived, 1 patient with DM and HTN but no COD who died, and 1 patient with CVD and not CKD who died. 2b, epilepsy in 1 patient with CVD and CKD who died. 2c, uterine cancer in 1 patient with CVD and not CKD who died. COD, chronic organ damage; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; HTN, hypertension. Age was associated with presence of DM (mean 59 years vs. 30 years; p<0.0001, by t-test), hypertension (mean 64 years vs. 36 years; p<0.0001 by t-test), and cardiovascular disease (median 66 years vs. 41 years; p<0.0001 by t-test). Sex was not significantly associated with DM (68% of patients with DM were male vs. 45% of patients without DM; p = 0.2159 by χ2 test), hypertension (67% of patients with hypertension were male vs. 59% of patients without hypertension; p = 0.6474 by χ2 test), or cardiovascular disease (60% of patients with cardiovascular disease were male vs. 64% of patients without cardiovascular disease; p = 0.8439 by χ2 test). Of the 32 patients, 21 survived until discharge, including 8 who required supplemental oxygen during hospitalization. Eleven died in the hospital, all of whom required ventilatory support. Case-patients with multiple and more severe underlying conditions generally had worse clinical course and outcomes than those without these conditions (Figure; Appendix Table). Of the 11 case-patients with no DM or hypertension, 100% survived, as did all patients with DM but without hypertension or COD. In comparison, 2 (40%) of 5 with DM and hypertension but without COD died, and 9 (82%) of 11 with DM or hypertension and with COD died (Appendix Table). In a previous study (), DM, chronic lung disease, heart disease, and smoking were identified as underlying health conditions and behaviors associated with primary infection with MERS-CoV. Alqahtani et al. reported that DM, hypertension, cardiac disease, renal disease, and bronchial asthma were frequent underlying conditions associated with death of MERS-CoV-infected patients and also found that the risk for death increased for patients with multiple comorbidities (). We found that DM, hypertension, and COD co-occurred frequently in MERS-CoVinfected patients, and severity of illness and frequency of death were higher for patients with multiple and more severe underlying conditions. Further studies are necessary to better clarify the mechanisms that lead to severe outcomes among these patients. For case-patients infected with MERS-CoV, the presence and compounding of underlying conditions, including DM, hypertension, and, ultimately, COD, corresponded with an increasingly complicated clinical course and death. These findings indicate that increased clinical vigilance is warranted for patients with multiple and severe underlying conditions who are suspected of being infected with MERS-CoV.

Appendix

Additional information on diabetes mellitus, hypertension, and death among 32 patients with MERS-CoV infection, Saudi Arabia.
  4 in total

1.  Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014.

Authors:  Basem M Alraddadi; John T Watson; Abdulatif Almarashi; Glen R Abedi; Amal Turkistani; Musallam Sadran; Abeer Housa; Mohammad A Almazroa; Naif Alraihan; Ayman Banjar; Eman Albalawi; Hanan Alhindi; Abdul Jamil Choudhry; Jonathan G Meiman; Magdalena Paczkowski; Aaron Curns; Anthony Mounts; Daniel R Feikin; Nina Marano; David L Swerdlow; Susan I Gerber; Rana Hajjeh; Tariq A Madani
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

2.  Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia.

Authors:  Hail M Al-Abdely; Claire M Midgley; Abdulrahim M Alkhamis; Glen R Abedi; Xiaoyan Lu; Alison M Binder; Khalid H Alanazi; Azaibi Tamin; Weam M Banjar; Sandra Lester; Osman Abdalla; Rebecca M Dahl; Mutaz Mohammed; Suvang Trivedi; Homoud S Algarni; Senthilkumar K Sakthivel; Abdullah Algwizani; Fahad Bafaqeeh; Abdullah Alzahrani; Ali Abraheem Alsharef; Raafat F Alhakeem; Hani A Aziz Jokhdar; Sameeh S Ghazal; Natalie J Thornburg; Dean D Erdman; Abdullah M Assiri; John T Watson; Susan I Gerber
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

3.  Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study.

Authors:  F Y Alqahtani; F S Aleanizy; R Ali El Hadi Mohamed; M S Alanazi; N Mohamed; M M Alrasheed; N Abanmy; T Alhawassi
Journal:  Epidemiol Infect       Date:  2018-11-05       Impact factor: 2.451

4.  Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.

Authors:  Abdullah Assiri; Jaffar A Al-Tawfiq; Abdullah A Al-Rabeeah; Fahad A Al-Rabiah; Sami Al-Hajjar; Ali Al-Barrak; Hesham Flemban; Wafa N Al-Nassir; Hanan H Balkhy; Rafat F Al-Hakeem; Hatem Q Makhdoom; Alimuddin I Zumla; Ziad A Memish
Journal:  Lancet Infect Dis       Date:  2013-07-26       Impact factor: 25.071

  4 in total
  23 in total

1.  COVID-19: A Personalized Cardiometabolic Approach for Reducing Complications and Costs. The Role of Aging Beyond Topics.

Authors:  J Saban-Ruiz; D Ly-Pen
Journal:  J Nutr Health Aging       Date:  2020-05-12       Impact factor: 4.075

2.  Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in Seattle, Washington.

Authors:  Frederick S Buckner; Denise J McCulloch; Vidya Atluri; Michela Blain; Sarah A McGuffin; Arun K Nalla; Meei-Li Huang; Alex L Greninger; Keith R Jerome; Seth A Cohen; Santiago Neme; Margaret L Green; Helen Y Chu; H Nina Kim
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

3.  Characteristics Associated with Hospitalization Among Patients with COVID-19 - Metropolitan Atlanta, Georgia, March-April 2020.

Authors:  Marie E Killerby; Ruth Link-Gelles; Sarah C Haight; Caroline A Schrodt; Lucinda England; Danica J Gomes; Mays Shamout; Kristen Pettrone; Kevin O'Laughlin; Anne Kimball; Erin F Blau; Eleanor Burnett; Chandresh N Ladva; Christine M Szablewski; Melissa Tobin-D'Angelo; Nadine Oosmanally; Cherie Drenzek; David J Murphy; James M Blum; Julie Hollberg; Benjamin Lefkove; Frank W Brown; Tom Shimabukuro; Claire M Midgley; Jacqueline E Tate
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-06-26       Impact factor: 17.586

4.  Cardiovascular comorbidity and its impact on patients with COVID-19.

Authors:  Wei-Jie Guan; Wen-Hua Liang; Jian-Xing He; Nan-Shan Zhong
Journal:  Eur Respir J       Date:  2020-06-11       Impact factor: 16.671

5.  Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.

Authors:  Sufei Wang; Pei Ma; Shujing Zhang; Siwei Song; Zhihui Wang; Yanling Ma; Juanjuan Xu; Feng Wu; Limin Duan; Zhengrong Yin; Huilin Luo; Nian Xiong; Man Xu; Tianshu Zeng; Yang Jin
Journal:  Diabetologia       Date:  2020-07-10       Impact factor: 10.122

Review 6.  Diabetes and COVID-19: A systematic review on the current evidences.

Authors:  Alireza Abdi; Milad Jalilian; Pegah Ahmadi Sarbarzeh; Zeljko Vlaisavljevic
Journal:  Diabetes Res Clin Pract       Date:  2020-07-22       Impact factor: 5.602

7.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.

Authors:  Wei-Jie Guan; Wen-Hua Liang; Yi Zhao; Heng-Rui Liang; Zi-Sheng Chen; Yi-Min Li; Xiao-Qing Liu; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Chun-Quan Ou; Li Li; Ping-Yan Chen; Ling Sang; Wei Wang; Jian-Fu Li; Cai-Chen Li; Li-Min Ou; Bo Cheng; Shan Xiong; Zheng-Yi Ni; Jie Xiang; Yu Hu; Lei Liu; Hong Shan; Chun-Liang Lei; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Lin-Ling Cheng; Feng Ye; Shi-Yue Li; Jin-Ping Zheng; Nuo-Fu Zhang; Nan-Shan Zhong; Jian-Xing He
Journal:  Eur Respir J       Date:  2020-05-14       Impact factor: 16.671

8.  Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia).

Authors:  Cem Haymana; Ibrahim Demirci; Ilker Tasci; Erman Cakal; Serpil Salman; Derun Ertugrul; Naim Ata; Ugur Unluturk; Selcuk Dagdelen; Aysegul Atmaca; Mustafa Sahin; Osman Celik; Tevfik Demir; Rifat Emral; Ibrahim Sahin; Murat Caglayan; Ilhan Satman; Alper Sonmez
Journal:  Endocrine       Date:  2021-06-22       Impact factor: 3.633

9.  Impact of comorbidities on patients with COVID-19: A large retrospective study in Zhejiang, China.

Authors:  Chanyuan Ye; Shanyan Zhang; Xiaoli Zhang; Huan Cai; Jueqing Gu; Jiangshan Lian; Yingfeng Lu; Hongyu Jia; Jianhua Hu; Ciliang Jin; Guodong Yu; Yimin Zhang; Jifang Sheng; Yida Yang
Journal:  J Med Virol       Date:  2020-06-29       Impact factor: 20.693

10.  COVID-19: A Personalized Cardiometabolic Approach for Reducing Complications and Costs. The Role of Aging beyond Topics.

Authors:  J Saban-Ruiz; D Ly-Pen
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.